Although ALA may improve NAFLD via formation functional EPA and DHA, it is also possible that ALA directly actively select receptors, such as PPAR-α, influence cellular metabolic processes, or modulate inflammatory pathways. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.